| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000027875 |
| Receipt No. | R000031938 |
| Scientific Title | Prospective Observational Study of Elective Neck Dissection for clinical N0 Tongue Cancer |
| Date of disclosure of the study information | 2017/06/22 |
| Last modified on | 2020/08/23 (Ver. 4) |
| Basic information | ||
| Public title | Prospective Observational Study of Elective Neck Dissection for clinical N0 Tongue Cancer | |
| Acronym | END-TC | |
| Scientific Title | Prospective Observational Study of Elective Neck Dissection for clinical N0 Tongue Cancer | |
| Scientific Title:Acronym | END-TC | |
| Region |
|
|
| Condition | |||
| Condition | clinical N0 squamous cell carcinoma of tongue | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Verify the efficacy of elective neck dissection for cN0 tongue cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 3 year-overall survival rate |
| Key secondary outcomes | 3 year-disease-specific survival rate, 3 year-relapse-free survival rate, quality of life evaluation |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) squamous cell carcinoma of the tongue2) Clinical and diagnostic imaging is cN0 in UICC 7th and 8th editions
3) No apparent distant metastasis 4) The age at the time of consent acquisition is 20 years old or over 5) PS (ECOG) is 0 or 1 6) Main organ function is maintained and curative surgery is possible 7) Document consent has been obtained regarding participation of this research by radical curative surgery |
|||
| Key exclusion criteria | 1) Cases with history of treatment with malignant tumors in head and neck area
2) Cases with active multiple cancer with a disease-free period of less than 5 years back from the date of registration (healed skin basal cell carcinoma and cervical carcinoma, or gastric cancer cured by endoscopic mucosal resection, esophageal carcinoma, Colorectal cancer cases can be registered) 3) Case in which psychosis or psychiatric symptoms are complicated and it is judged that it is difficult to participate in this study 4) Other cases that the physician judged inappropriate as the subject of this study |
|||
| Target sample size | 800 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University | ||||||
| Division name | Department of Clinical Oral Oncology | ||||||
| Zip code | 852-8588 | ||||||
| Address | 1-7-1 Sakamoto, Nagasaki | ||||||
| TEL | 095-819-7698 | ||||||
| mumeda@nagasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University | ||||||
| Division name | Dentistry for Medically Compromised Patient | ||||||
| Zip code | 852-8588 | ||||||
| Address | 1-7-1 Sakamoto, Nagasaki | ||||||
| TEL | 095-819-7698 | ||||||
| Homepage URL | |||||||
| syana@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagasaki University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagasaki University |
| Organization | |
| Division | |
| Category of Funding Organization | Government offices of other countries |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagasaki University Hospital Clinical Research Ethics Committee |
| Address | 1-7-1 Sakamoto, Nagasaki |
| Tel | 095-819-7229 |
| gaibushikin@ml.nagasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | After enrolling a patient with curative cN0 tongue squamous cell carcinoma capable of curative surgery, radical surgery was performed, patients were divided between patients who had undergone prophylactic cervical dissection and patients who did not undergo radical surgery, and prospective observational studies.
The observation items are as follows. 1) Information on registration Patient information, Disease information, ECOG systemic symptom scale, radical surgery day, Life history, Allergy, History of history, Evaluation of primary lesion: site, depth of tumor (Depth of Invasion; DOI mm) , US, others), Preoperative treatment, QOL evaluation: FACT-H&N ver. 4 Japanese version and DASH Japanese version, Perioperative period Oral function management 2) Information on treatment surgical contents, postoperative pathological examination, postoperative adjuvant therapy 3) Observation information Palpation or US is essential. Combine head and neck contrast CT or MRI once every 3 months. Chest radiograph or chest or abdominal CT are performed once every 6 months after treatment is completed. Observation date, Observation method, Outcome, recurrence, Secondary cancer, QOL evaluation, Late cervical lymph node metastasis appearance, postoperative adjuvant chemotherapy when the treatment of cervical lymphadenectomy is performed. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031938 |